1.
Fogarty P, Seggewiss R, McCloskey D, Boss C, Dunbar C, Rick M. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura. Haematologica [Internet]. 2006Feb.1 [cited 2026Nov.16];91(2):277-8. Available from: https://haematologica.org/article/view/3863